Home / Pharma Healthcare / Pain Management Drugs and Devices - Global Market

Pain Management Drugs and Devices - Global Market

  • Id : RNR-53830
  • Category : Pharma Healthcare
  • Publish Date : October 2016
  • Pages : 0
  • Format : PDF
License Type

Description
According to Stratistics MRC, the Global Pain Management Drugs and Devices market is expected to grow from $39.48 billion in 2015 to reach $58.2 billion by 2022 with a CAGR of 5.7%. Growing various pain disorders coupled with increasing global geriatric people is the major factor propelling the pain management drugs and devices market. Furthermore, rapid technological developments, growing healthcare industry across the globe are some of the factors boosting the market growth. However, intensified competition between companies and lack of skilled professionals are the factors inhibiting the market growth.

The Neuromodulation device leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to increasing chronic back pain. By drugs, opiods segment commands the market accounting for more than 42% of the total market. North America is anticipated to hold the largest share in global pain management drugs and devices market due to increasing demand from U.S. and Asia Pacific is likely to grow at a fastest rate during the forecast period.

Some of the key players in global pain management drugs and devices market include Abbvie Inc., Astrazeneca Depomed Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Eli Lilly & Co., Glaxosmithkline, Halyard Health, Inc., Hisamitsu Pharmaceutical Co. Inc, Johnson & Johnson, Medtronic PLC, Neurotech Na, Inc. (A Subsidiary of Theragen LLC), Nevro Corp., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, Smiths Medical, and ST. Jude Medical, Inc. 

Drug Classes Covered:
• Anti-Migraine Agents
• Non-Narcotic Analgesics
• Opioids
• NSAIDS
• Anesthetics
• Anticovulsants
• Antidepressent

Device Types Covered:
• Analgesic Infusion Pumps
o External Infusion Pumps
o Intrathecal Infusion Pumps
• Ablation Devices
o Cryoablation Devices
o Radiofrequency Ablation Devices
• Electrical stimulation devices
o Neuromuscular Electrical Stimulation (NMES/EMS) Devices
o Transcutaneous Electrical Nerve Stimulation (TENS) Devices
o Other Electrical Stimulation Devices
• Neuromodulation Devices
o Sacral Nerve Stimulation Devices
o Deep Brain Stimulation Devices
o Vagus Nerve Stimulation Devices
o Spinal Cord Stimulation (SCS) Devices

Indications Covered:
• Arthritic pain
• Cancer pain
• Migraine
• Fibromyalgia
• Chronic back pain
• Neuropathic pain
• Post-operative pain

Applications Covered:
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Neuropathic Pain
• Other Applications
o Post-operative Pain
o Pregnancy/Labor and Menstrual Pain
o Sports Injuries
o Trauma Pain

Mode of Purchase Covered:
• Prescription-based Devices
• Over-the-counter Devices

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements